Sophie Jamal
Canadian endocrinologist / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Sophie Jamal?
Summarize this article for a 10 year old
Abida Sophie Jamal (born on 6 June 1966) is a Canadian endocrinologist and former osteoporosis researcher who was at the centre of a scientific misconduct case in the mid-to-late 2010s. Jamal published a high-profile paper suggesting that the heart medication nitroglycerin was a treatment for osteoporosis, and was later demonstrated to have misrepresented her results. She received a lifetime ban from receiving funding from the Canadian Institutes of Health Research and was named directly in their disclosure report, becoming the first person mentioned by name by the institute for scientific misconduct. Jamal was later stripped of her medical license for two years, regaining it in a controversial 3–2 decision.
Sophie Jamal | |
---|---|
Born | Abida Sophina Jamal (1966-06-06) June 6, 1966 (age 57) |
Nationality | Canadian |
Known for | Biomedical research fraud |
Medical career | |
Field | Endocrinology |
Research | Osteoporosis treatment |
Notable works | Effect of Nitroglycerin Ointment on Bone Density and Strength in Postmenopausal Women: A Randomized Trial (2011) |